- Messages
- 8,934
- Type of diabetes
- Type 1
- Treatment type
- Other
At ADA Scientific Sessions this weekend Medtronic and Omnipod announced results of some of their artificial pancreas or automated insulin delivery trials. This was alongside the Medtronic 780G European approval being announced.
I took a look at the data and how it compares to others in the marketplace. Suffice to say, the "Advanced Hybrid Closed Loop" 780G outcomes are still not as good as some of the existing players that are already available to users in the UK, including CamAPS.
For more info, read here: https://www.diabettech.com/uncategorized/more-commercial-aid-systems-what-do-the-trials-tell-us/
I took a look at the data and how it compares to others in the marketplace. Suffice to say, the "Advanced Hybrid Closed Loop" 780G outcomes are still not as good as some of the existing players that are already available to users in the UK, including CamAPS.
For more info, read here: https://www.diabettech.com/uncategorized/more-commercial-aid-systems-what-do-the-trials-tell-us/